Percutaneous ablation of small renal tumours: Current status

Miltiadis Krokidis


The detection rate of small renal cell carcinoma (RCC) has been significantly increased in the last twenty years due to the expansion of number of diagnostic scans performed for other reasons. The management of small, asymptomatic RCC generates significant controversy. The gold standard still remains surgical excision; nevertheless nephron sparing minimal invasive ablation treatment appears to offer similar oncologic outcomes and less complication than surgery. Active surveillance is only reserved for patients that are not suitable for any treatment. Purpose of this review article is to present the current evidence on the ablation of small RCC and to delineate the role of this minimal invasive treatment in the management conundrum of such patients.

Full Text:



European Network of Cancer Registries. Eurocim version 4.0. European incidence database V2.3, 730 entity dictionary (2001), Lyon, 2001.

Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer 2013; 49(6): 1374-1403.

Lindblad P. Epidemiology of renal cell carcinoma. Scand J Surg 2004; 93(2): 88-96.

Choyke PL, Glenn GM, Walther MM, et al. Hereditary renal cancers. Radiology 2003; 226: 33-46.

Linenham M, Rini B, Yang J. Cancer of the Kidney. In: DeVita, Hellman Rosenberg’s Cancer: Principles and Practice of Oncology (ed 9Th). Philadelphia, PA: Lipincott Williams & Wilkins 2011; 1161-1170.

Lipworth L, Tarone RE, McLaughlin JK. The epidemiology of renal cell carcinoma. J Urol 2006; 176 (6 Pt 1): 2353-2358.

Bergstrom A, Hsieh CC, Lindblad P, et al. Obesity and renal cell cancer-a quantitative review. Br J Cancer 2001; 85(7): 984-990.

Pischon T, Lahmann PH, Boeing H, et al. Body size and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 2006; 118(3): 728-738.

Weikert S, Boeing H, Pischon T, et al. Blood pressure and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition. Am J Epidemiol 2008; 167(4): 438-446.

Israel GM, Bosniak MA. How I do it: Evaluating renal masses. Radiology 2005; 236: 441-450.

Hricak H, Demas BE, Williams RD, et al. Magnentic resonance imaging in the diagnosis and staging of renal and perirenal neoplasms. Radiology 1985; 154: 709-715.


Choudhary S, Rajesh A, Mayer NJ, et al. Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasms. Clin Radiol 2009; 64(5): 517-522.

Gervais DA, McGovern FJ, Arellano RS, et al. Radiofrequency ablation of renal cell carcinoma. Part 1. Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR 2005; 185: 64–71.

Tuncali K, vanSonnenberg E, Shankar S, et al. Evaluation of patients referred for percutaneous ablation of renal tumors: Importance of a preprocedure diagnosis. AJR 2004; 183: 575-582.

Heilbrun ME, Zagoria RJ, Garvin AJ, et al. CT guided biopsy for the diagnosis of renal tumors before treatment with percutaneous ablation. AJR 2007; 188: 1500-1505.

Breen DJ, Railton NJ. Minimally invasive treatment of small renal tumors: Trends in renal cancer diagnosis and management. Cardiovasc Intervent Radiol. 2010; 33(5): 896-908.

Shannon BA, Cohen RJ, de Bruto H, et al. The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses. J Urol 2008; 180(4): 1257-1261.

Schmidbauer J, Remzi M, Memarsadeghi M, et al. Diagnostic accuracy of computed tomography guided percutaneous biopsy of renal masses. Eur Urol 2008; 53(5): 1003-1011.

Lebret T, Poulain JE, Molinie V, et al. Percutaneous core biopsy for renal masses: indications, accuracy and results. J Urol 2007; 178(4 Pt 1): 1184-1188.

Maturen KE, Nghiem HV, Caoili EM, et al. Renal mass core biopsy: accuracy and impact on clinical management. AJR Am J Roentgenol 2007; 188(2): 563-570.

McDougal WS, Gervais DA, McGovern FJ, et al. Long-term followup of patients with renal cell carcinoma treated with radio frequency ablation with curative intent. J Urol 2005; 174: 61-63.

Farrell MA, Charboneau WJ, DiMarco DS. Imaging- guided radiofrequency ablation of solid renal tumors. AJR Am J Roentgenol 2003; 180: 1509-1513.

Zagoria RJ, Hawkins AD, Clark PE, et al. Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success. AJR Am J Roentgenol 2004; 183: 201-207.

Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 2000; 174(2): 323-331.

Krokidis M, Spiliopoulos S, Jarzabek M, et al. Percutaneous radiofrequency ablation of small renal tumours in patients with a single functioning kidney: Long-term results. Eur Radiol 2013; 23(7): 1933-1939.

Mylona S, Kokkinaki A, Pomoni M, et al. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with solitary kidney: 6 years experience. Eur J Radiol 2008; 69: 351-356.

Olweny EO, Park SK, Tan YK, et al. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: Comparable oncologic outcomes at a minimum of 5 years of follow-up. Eur Urol. 2012; 61(6): 1156-1161.

Sung HH, Park BK, Kim CK, et al. Comparison of percutaneous radiofrequency ablation and open partial nephrectomy for the treatment of size -and location- matched renal masses. Int J Hyperthermia 2012; 28(3): 227-234.

Stern JM, Svatek R, Park S, et al. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours. BJU Int. 2007; 100(2): 287-290.

Psutka SP, Feldman AS, McDougal WS, et al. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol 2013; 63(3): 486-492.

Hoffmann NE, Bischof JC. The cryobiology of cryosurgical injury. Urology 2002; 60 (2 Suppl 1): 40-49.

Georgiades C, Rodriguez R, Azene E, et al. Determination of the nonlethal margin inside the visible “ice-ball” during percutaneous cryoablation of renal tissue. Cardiovasc Intervent Radiol 2013; 36(3): 783-790.

Weld KJ, Hruby G, Humphrey PA, et al. Precise characterization of renal parenchymal response to single and multiple cryoablation probes. J Urol 2006; 176(2): 78478-78486.

Breen D, Bryant TJ, Abbas A, et al. Percutaneous cryoablation of renal tumours: Outcomes from 171 tumours in 147 patients. BJU Int 2013; 112(6): 758-765.

Georgiades CS, Rodriguez R. Efficacy and safety of percutaneous cryoablation for stage 1A/B renal cell carcinoma: Results of a prospective, single-arm, 5-year study. Cardiovasc Intervent Radiol 2014; 37(6): 1494-1499.

Chehab M, Friedlander JA, Handel J, et al. Percutaneous Cryoablation vs Partial Nephrectomy: Cost Comparison of T1a Tumors. J Endourol 2016; 30 (2): 170-176

Lubner MG, Brace CL, Ziemlewicz TJ, Hinshaw JL, Lee FT Jr. Microwave ablation of hepatic malignancy. Semin Intervent Radiol 2013; 30(1): 56-66.

Wright AS, Sampson LA, Warner TF, et al. Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology 2005; 236: 132-139.

Guan W, Bai J, Liu J, et al. Microwave ablation versus partial nephrectomy for small renal tumors: Intermediate-term results. J Surg Oncol 2012; 106(3): 316-321.

Yu J, Zhang G, Liang P, et al. Midterm results of percutaneous microwave ablation under ultrasound guidance versus retroperitoneal laparoscopic radial nephrectomy for small renal cell carcinoma. Abdom Imaging 2015; 40(8): 3248-3256.

Wells SA, Wheeler KM, Mithqal A, et al. Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: Short-term efficacy and complications with emphasis on tumor complexity and single session treatment. Abdom Radiol (NY) 2016; 41(6): 1203-1211.

Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng 2005; 33: 223-231.

Rubinsky B, Onik G, Mikus P. Irreversible electroporation: A new ablation modality-clinical implications. Technol Cancer Res Treat 2007; 6: 37-48.

Pech M, Janitzky A, Wendler JJ, et al. Irreversible electroporation of renal cell carcinoma: A first-in-man phase I clinical study. Cardiovasc Intervent Radiol 2011; 34(1): 132-138.

Trimmer CK, Khosla A, Morgan M, et al. Minimally invasive percutaneous treatment of small renal tumors with irreversible electroporation: A single-centre experience. J Vasc Interv Radiol 2015; 26(10): 1465-1471.

Gervais DA, McGovern FJ, Arellano RS, et al. Renal cell carcinoma: Clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology 2003; 226: 417-424.

Wah TM, Irving HC, Gregory W, et al. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): Experience in 200 tumours. BJU Int 2014; 113(3): 416-428.

Wah TM, Koenig P, Irving HC, et al. Radiofrequency ablation of a central renal tumour: Protection of the collecting system with a retrograde cold dextrose pyeloperfusion technique. J Vasc Interv Radiol 2005; 16(11): 1551-1555.

Cantwell CP, Wah TM, Gervais DA, et al. Protecting the ureter during radiofrequency ablation of renal cell cancer: A pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water. J Vasc Interv Radiol 2008; 19(7): 1034-1040.

Boss A, Clasen S, Kuczyk M, et al. Thermal damage of the genitofemoral nerve due to radiofrequency ablation of renal cell carcinoma: A potentially avoidable complication. AJR Am J Roentgenol 2005; 185(6): 1627-1631.

Kam AW, Littrup PJ, Walther MM, et al. Thermal protection during percutaneous thermal ablation of renal cell carcinoma. J Vasc Interv Radiol 2004; 15(7): 753-758.

Wang X, Zhao X, Lin T, et al. Thermo-sensitive hydrogel for preventing bowel injury in percutaneous renal radiofrequency ablation. Int Urol Nephrol 2016.

Ginat D, Saad WE. Bowel displacement and protection techniques during percutaneous renal tumor thermal ablation. Tech Vasc Interventional Rad 2010; 13: 66-74.

Atwell TD, Schmit GD, Boorjian SA, et al. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: Comparative local control and complications after radiofrequency ablation and cryoablation. AJR Am J Roentgenol 2013; 200(2): 461-466.

Thompson RH, Atwell T, Schmit G, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015; 67(2): 252-259.

Ma Y, Bedir S, Cadeddu JA, et al. Long-term outcomes in healthy adults after radiofrequency ablation of T1a renal tumours. BJU Int 2014; 113: 51-55.

Katsanos K, Mailli L, Krokidis M, et al. Systematic review and meta-analysis of thermal ablation versus surgical nephrectomy for small renal tumours. Cardiovasc Intervent Radiol 2014; 37(2): 427-437.

Yang Y, Chen S, Chen F, et al. Outcome of radiofrequency ablation over partial nephrectomy for small renal mass (<4 cm): A systematic review and meta-analysis. Int J Clin Exp Med. 2015 15; 8 (11): 20670-20674.

Yin X, Cui L, Li F, et al. Radiofrequency Ablation Versus Partial Nephrectomy in Treating Small Renal Tumors: A Systematic Review and Meta-Analysis. Medicine (Baltimore) 2015; 94(50): e2255.


  • There are currently no refbacks.